John Chan, MD

Title(s)Associate Clinical Professor, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
Address1600 Divisadero
San Francisco CA 94115
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    John K. Chan, MD, is the Director of Gynecologic Oncology and a specialist in the surgical and medical treatment of ovarian and other complex pelvic cancers at the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Chan oversees the Division’s activities and development in patient care, research and education. His research focuses on developing new therapies for gynecologic cancers, including genomic therapy and targeted biologic therapies, as well as investigating the role of tumor-initiating cells in ovarian cancer. He is involved in population-based studies examining treatment and health outcome of ovarian and uterine cancer patients. Dr. Chan has also recently been appointed the principal investigator one of the largest advanced ovarian cancer clinical trials in the world, which is currently under development at the National Cancer Institute.

    Collapse Research 
    Collapse Research Activities and Funding
    Prophylactic oophorectomy: practice patterns &outcomes
    NIH R03AG032602Aug 15, 2008 - Jul 31, 2010
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance. Gynecol Oncol. 2020 12; 159(3):604-606. Chan JK, Liang SY, Kapp DS, Chan JE, Herzog TJ, Coleman RL, Monk BJ, Richardson MT. PMID: 32994055.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Hospital-acquired conditions after surgery for gynecologic cancer - An analysis of 82,304 patients. Gynecol Oncol. 2018 09; 150(3):515-520. Chan JK, Gardner AB, Mann AK, Kapp DS. PMID: 30037490.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Metastatic gynecologic malignancies: advances in treatment and management. Clin Exp Metastasis. 2018 08; 35(5-6):521-533. Chan JK, Chow S, Bhowmik S, Mann A, Kapp DS, Coleman RL. PMID: 29931499.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    4. A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254). Gynecol Oncol. 2018 08; 150(2):247-252. Chan JK, Brady W, Monk BJ, Brown J, Shahin MS, Rose PG, Kim JH, Secord AA, Walker JL, Gershenson DM. PMID: 29921512.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    5. Clear Cell Ovarian Cancer: Optimum Management and Prognosis Remain Hazy. Gynecol Oncol. 2017 11; 147(2):237-239. Chan JK, Kapp DS. PMID: 29096823.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 09; 146(3):554-559. Chan JK, Deng W, Higgins RV, Tewari KS, Bonebrake AJ, Hicks M, Gaillard S, Ramirez PT, Chafe W, Monk BJ, Aghajanian C. PMID: 28728751.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    7. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials. Gynecol Oncol. 2016 Dec; 143(3):490-495. Chan JK, Java JJ, Fuh K, Monk BJ, Kapp DS, Herzog T, Bell J, Young R. PMID: 27771168.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. The influence of age and other prognostic factors associated with survival of ovarian immature teratoma - A study of 1307 patients. Gynecol Oncol. 2016 09; 142(3):446-51. Chan JK, Gardner AB, Chan JE, Guan A, Alshak M, Kapp DS. PMID: 27423379.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Racial disparities in presentation and survival of ovarian yolk sac cancer patients: a study of 423 women. Am J Obstet Gynecol. 2016 08; 215(2):248-9. Chan JK, Gardner AB, Liao CI, Chan J, Guan A, Alshak M, Kapp DS. PMID: 27156674.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Reply to F.M. Muggia. J Clin Oncol. 2016 Mar 10; 34(8):882-3. Chan JK, Monk BJ. PMID: 26834062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients - a comparative analysis of total charges and complication rates. Gynecol Oncol. 2015 Nov; 139(2):300-5. Chan JK, Gardner AB, Taylor K, Thompson CA, Blansit K, Yu X, Kapp DS. PMID: 26363212.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    12. The use of clinical characteristics to help prevent morcellation of leiomyosarcoma: An analysis of 491 cases. Am J Obstet Gynecol. 2015 Dec; 213(6):873-4. Chan JK, Gardner AB, Thompson CA, Kapp DS. PMID: 26226552.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. The centralization of robotic surgery in high-volume centers for endometrial cancer patients--a study of 6560 cases in the U.S. Gynecol Oncol. 2015 Jul; 138(1):128-32. Chan JK, Gardner AB, Taylor K, Blansit K, Thompson CA, Brooks R, Yu X, Kapp DS. PMID: 25933680.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008 Oct 21; 99(8):1210-5. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS. PMID: 18813312.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    15. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer. 2008 Apr 08; 98(7):1191-6. Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K. PMID: 18349835.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    16. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007 Jun 18; 96(12):1817-22. Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS. PMID: 17519907.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    John's Networks
    Concepts (112)
    Derived automatically from this person's publications.
    Co-Authors (3)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department